Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.530
+0.040 (1.15%)
Aug 7, 2026, 10:56 AM EDT - Market open
Psyence Biomedical Employees
Psyence Biomedical had 12 employees as of March 31, 2025.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$578,035
Market Cap
13.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Senti Biosciences Holdings | 39 |
| Lunai Bioworks | 29 |
| BioLineRx | 24 |
| SeaStar Medical Holding | 17 |
| CalciMedica | 16 |
| Intensity Therapeutics | 7 |
| Phio Pharmaceuticals | 6 |
PBM News
- 7 weeks ago - Tredium Solutions Selected to Support Scripius' Pharmacy Benefits Platform - Business Wire
- 3 months ago - Psyence Biomedical announces U.S. engagement initiative focused on ibogaine - TheFly
- 3 months ago - Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - GlobeNewsWire
- 3 months ago - Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder - GlobeNewsWire
- 3 months ago - Psyence Biomedical provides update on position in global ibogaine market - TheFly
- 3 months ago - Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - GlobeNewsWire
- 3 months ago - Why Is Psyence Biomedical Stock (PBM) Up Today? - TipRanks
- 3 months ago - Psyence Biomedical Ltd trading resumes - TheFly